Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Apr 8, 2026 · Quart Barry D sold 6,901 shares at $50.00/share ($345.1K); exercised options for 6,901 shares

Quart Barry D sold 6,901 shares at $50.00/share ($345.1K); exercised options for 6,901 shares

xslF345X06/form4-04082026_080443.xml

xslF345X06/form4-04082026_080443.xmlSEC.gov

Graphics and non-inline formats (not embedded below).